These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8313643)

  • 21. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease.
    Kamada A; Saga K; Jimbow K
    J Am Acad Dermatol; 2003 Mar; 48(3):453-5. PubMed ID: 12637930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fox-Fordyce disease: report of two cases with perifollicular xanthomatosis on histological image.
    Vega-Memije ME; Pérez-Rojas DO; Boeta-Ángeles L; Valdés-Landrum P
    An Bras Dermatol; 2018; 93(4):562-565. PubMed ID: 30066765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Linacidin for the treatment of Fox-Fordyce disease].
    Janson P
    Landarzt; 1964 Jun; 40(16):702-3. PubMed ID: 5825899
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid remission with calcipotriol betamethasone in refractory Fox-Fordyce disease.
    Yang L; Zhang S; Wang T; He Z; Liu Y; Zdravković TP
    Dermatol Ther; 2020 Mar; 33(2):e13223. PubMed ID: 31917488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fox Fordyce's disease].
    Dehen L; Vilmer C
    Ann Dermatol Venereol; 2003; 130(6-7):670-1. PubMed ID: 13679712
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A.
    González-Ramos J; Alonso-Pacheco ML; Goiburú-Chenú B; Mayor-Ibarguren A; Herranz-Pinto P
    Br J Dermatol; 2016 Feb; 174(2):458-9. PubMed ID: 26385128
    [No Abstract]   [Full Text] [Related]  

  • 27. Fox-Fordyce disease treated with topical clindamycin solution.
    Miller ML; Harford RR; Yeager JK
    Arch Dermatol; 1995 Oct; 131(10):1112-3. PubMed ID: 7574824
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of pruritus with botulinum toxin in a pediatric patient with Fox-Fordyce disease.
    Klager S; Kumar MG
    Pediatr Dermatol; 2021 Jul; 38(4):950-951. PubMed ID: 34060125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fox-Fordyce disease: a report of 2 cases responding to topical clindamycin.
    George A; Bhatia A; Thomas E
    Indian J Dermatol Venereol Leprol; 2015; 81(1):87-8. PubMed ID: 25566917
    [No Abstract]   [Full Text] [Related]  

  • 30. Fox-Fordyce disease.
    Ozcan A; Senol M; Aydin NE; Karaca S; Sener S
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):244-5. PubMed ID: 12705772
    [No Abstract]   [Full Text] [Related]  

  • 31. Fox-Fordyce disease. Control with tretinoin cream.
    Giacobetti R; Caro WA; Roenigk HH
    Arch Dermatol; 1979 Nov; 115(11):1365-6. PubMed ID: 507892
    [No Abstract]   [Full Text] [Related]  

  • 32. Fox-Fordyce disease: diagnosis with transverse histologic sections.
    Stashower ME; Krivda SJ; Turiansky GW
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):89-91. PubMed ID: 10607326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathology attributes of Fox-Fordyce disease.
    Brau Javier CN; Morales A; Sanchez JL
    Int J Dermatol; 2012 Nov; 51(11):1313-8. PubMed ID: 23067079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [UROLOGICAL ASPECTS OF THE FOX - FORDYCE DISEASE].
    Dutov VV; Romanov DV
    Urologiia; 2015; (1):108-10. PubMed ID: 26094399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histopathological picture of a case of Fox-Fordyce disease in a 14-year-old boy].
    Kudzielka-Stankiewicz D
    Przegl Dermatol; 1969; 56(2):207-10. PubMed ID: 5790579
    [No Abstract]   [Full Text] [Related]  

  • 36. Fox-Fordyce disease with an atypical clinical presentation.
    Ballester I; López-Ávila A; Ortiz S
    Actas Dermosifiliogr; 2013 Nov; 104(9):832-4. PubMed ID: 23260875
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fox-Fordyce disease].
    Baccouche D; Denguezli M; Ghariani N; Boussofara L; Mokni M; Belajouza C; Nouira R
    Ann Dermatol Venereol; 2007 Jan; 134(1):101-2. PubMed ID: 17384561
    [No Abstract]   [Full Text] [Related]  

  • 38. Fox-Fordyce disease: successful treatment with topical clindamycin in alcoholic propylene glycol solution.
    Feldmann R; Masouyé I; Chavaz P; Saurat JH
    Dermatology; 1992; 184(4):310-3. PubMed ID: 1498406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A female case of Fox-Fordyce disease.
    Roche H; Roche-Kubler B; Blanc D; Algros MP; Faivre B; Aubin F
    Eur J Dermatol; 2016 Apr; 26(2):212-3. PubMed ID: 27226051
    [No Abstract]   [Full Text] [Related]  

  • 40. Apocrine sweat retention in man. II. Fox-Fordyce disease (apocrine miliaria).
    SHELLEY WB; LEVY EJ
    AMA Arch Derm; 1956 Jan; 73(1):38-49. PubMed ID: 13275123
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.